Larvol Delta - A-Study-to-Evaluate-Safety-and-Efficacy-of-ACT001-and-AntiPD1-in-Patients-With-Surgically-Accessible-Recurrent-Glioblastoma-Multiforme

dimethylamino micheliolide (ACT001) - Tianjin Suntech Pharma

Keytruda (pembrolizumab) - Merck (MSD)

http://clinicaltrials.gov/ct2/show/NCT05053880

Jun 11, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next